{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:10:45Z","timestamp":1791940245232,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,1,20]],"date-time":"2014-01-20T00:00:00Z","timestamp":1390176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,1,20]],"date-time":"2014-01-20T00:00:00Z","timestamp":1390176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2015,1,15]]},"DOI":"10.1038\/onc.2013.583","type":"journal-article","created":{"date-parts":[[2014,1,20]],"date-time":"2014-01-20T11:29:13Z","timestamp":1390217353000},"page":"357-363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Dual role of SIRT1 in UVB-induced skin tumorigenesis"],"prefix":"10.1038","volume":"34","author":[{"given":"M","family":"Ming","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C R","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y Y","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,20]]},"reference":[{"key":"BFonc2013583_CR1","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1101\/gad.1467506","volume":"20","author":"MC Haigis","year":"2006","unstructured":"Haigis MC, Guarente LP . Mammalian sirtuins\u2014emerging roles in physiology, aging, and calorie restriction. Genes Dev 2006; 20: 2913\u20132921.","journal-title":"Genes Dev"},{"key":"BFonc2013583_CR2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1146\/annurev.biochem.73.011303.073651","volume":"73","author":"G Blander","year":"2004","unstructured":"Blander G, Guarente L . The Sir2 family of protein deacetylases. Annu Rev Biochem 2004; 73: 417\u2013435.","journal-title":"Annu Rev Biochem"},{"key":"BFonc2013583_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20070140","volume":"404","author":"S Michan","year":"2007","unstructured":"Michan S, Sinclair D . Sirtuins in mammals: insights into their biological function. Biochem J 2007; 404: 1\u201313.","journal-title":"Biochem J"},{"key":"BFonc2013583_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1146\/annurev.pathol.4.110807.092250","volume":"5","author":"MC Haigis","year":"2010","unstructured":"Haigis MC, Sinclair DA . Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol 2010; 5: 253\u2013295.","journal-title":"Annu Rev Pathol"},{"key":"BFonc2013583_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrc2562","volume":"9","author":"CL Brooks","year":"2009","unstructured":"Brooks CL, Gu W . How does SIRT1 affect metabolism, senescence and cancer? Nat Rev Cancer 2009; 9: 123\u2013128.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2013583_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.7150\/ijbs.5.147","volume":"5","author":"CX Deng","year":"2009","unstructured":"Deng CX . SIRT1, is it a tumor promoter or tumor suppressor? Int J Biol Sci 2009; 5: 147\u2013152.","journal-title":"Int J Biol Sci"},{"key":"BFonc2013583_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0092-8674(01)00524-4","volume":"107","author":"J Luo","year":"2001","unstructured":"Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A et al. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 2001; 107: 137\u2013148.","journal-title":"Cell"},{"key":"BFonc2013583_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0092-8674(01)00527-X","volume":"107","author":"H Vaziri","year":"2001","unstructured":"Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001; 107: 149\u2013159.","journal-title":"Cell"},{"key":"BFonc2013583_CR9","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0092-8674(01)00619-5","volume":"107","author":"C Prives","year":"2001","unstructured":"Prives C, Manley JL . Why is p53 acetylated? Cell 2001; 107: 815\u2013818.","journal-title":"Cell"},{"key":"BFonc2013583_CR10","doi-asserted-by":"publisher","first-page":"6612","DOI":"10.1158\/0008-5472.CAN-07-0085","volume":"67","author":"DM Huffman","year":"2007","unstructured":"Huffman DM, Grizzle WE, Bamman MM, Kim JS, Eltoum IA, Elgavish A et al. SIRT1 is significantly elevated in mouse and human prostate cancer. Cancer Res 2007; 67: 6612\u20136618.","journal-title":"Cancer Res"},{"key":"BFonc2013583_CR11","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/sj.leu.2403910","volume":"19","author":"CA Bradbury","year":"2005","unstructured":"Bradbury CA, Khanim FL, Hayden R, Bunce CM, White DA, Drayson MT et al. Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. Leukemia 2005; 19: 1751\u20131759.","journal-title":"Leukemia"},{"key":"BFonc2013583_CR12","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/biot.200700087","volume":"2","author":"W Stunkel","year":"2007","unstructured":"Stunkel W, Peh BK, Tan YC, Nayagam VM, Wang X, Salto-Tellez M et al. Function of the SIRT1 protein deacetylase in cancer. Biotechnol J 2007; 2: 1360\u20131368.","journal-title":"Biotechnol J"},{"key":"BFonc2013583_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00403-006-0725-6","volume":"299","author":"Y Hida","year":"2007","unstructured":"Hida Y, Kubo Y, Murao K, Arase S . Strong expression of a longevity-related protein, SIRT1, in Bowen's disease. Arch Dermatol Res 2007; 299: 103\u2013106.","journal-title":"Arch Dermatol Res"},{"key":"BFonc2013583_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.molcel.2008.09.011","volume":"32","author":"RH Wang","year":"2008","unstructured":"Wang RH, Zheng Y, Kim HS, Xu X, Cao L, Luhasen T et al. Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis. Mol Cell 2008; 32: 11\u201320.","journal-title":"Mol Cell"},{"key":"BFonc2013583_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature01960","volume":"425","author":"KT Howitz","year":"2003","unstructured":"Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003; 425: 191\u2013196.","journal-title":"Nature"},{"key":"BFonc2013583_CR16","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S1097-2765(04)00094-2","volume":"13","author":"HY Cohen","year":"2004","unstructured":"Cohen HY, Lavu S, Bitterman KJ, Hekking B, Imahiyerobo TA, Miller C et al. Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. Mol Cell 2004; 13: 627\u2013638.","journal-title":"Mol Cell"},{"key":"BFonc2013583_CR17","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1126\/science.1099196","volume":"305","author":"HY Cohen","year":"2004","unstructured":"Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004; 305: 390\u2013392.","journal-title":"Science"},{"key":"BFonc2013583_CR18","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.ccr.2008.09.001","volume":"14","author":"RH Wang","year":"2008","unstructured":"Wang RH, Sengupta K, Li C, Kim HS, Cao L, Xiao C et al. Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell 2008; 14: 312\u2013323.","journal-title":"Cancer Cell"},{"key":"BFonc2013583_CR19","doi-asserted-by":"publisher","first-page":"e2020","DOI":"10.1371\/journal.pone.0002020","volume":"3","author":"R Firestein","year":"2008","unstructured":"Firestein R, Blander G, Michan S, Oberdoerffer P, Ogino S, Campbell J et al. The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One 2008; 3: e2020.","journal-title":"PLoS One"},{"key":"BFonc2013583_CR20","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.cell.2008.10.025","volume":"135","author":"P Oberdoerffer","year":"2008","unstructured":"Oberdoerffer P, Michan S, McVay M, Mostoslavsky R, Vann J, Park SK et al. SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell 2008; 135: 907\u2013918.","journal-title":"Cell"},{"key":"BFonc2013583_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/ncomms1001","volume":"1","author":"D Herranz","year":"2010","unstructured":"Herranz D, Munoz-Martin M, Canamero M, Mulero F, Martinez-Pastor B, Fernandez-Capetillo O et al. Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. Nat Commun 2010; 1: 3.","journal-title":"Nat Commun"},{"key":"BFonc2013583_CR22","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1158\/0008-5472.CAN-10-3172","volume":"71","author":"MJ Powell","year":"2011","unstructured":"Powell MJ, Casimiro MC, Cordon-Cardo C, He X, Yeow WS, Wang C et al. Disruption of a Sirt1-dependent autophagy checkpoint in the prostate results in prostatic intraepithelial neoplasia lesion formation. Cancer Res 2011; 71: 964\u2013975.","journal-title":"Cancer Res"},{"key":"BFonc2013583_CR23","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nrc2962","volume":"10","author":"D Herranz","year":"2010","unstructured":"Herranz D, Serrano M . SIRT1: recent lessons from mouse models. Nat Rev Cancer. 2010; 10: 819\u2013823.","journal-title":"Nat Rev Cancer."},{"key":"BFonc2013583_CR24","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.1038\/onc.2012.407","volume":"32","author":"D Herranz","year":"2013","unstructured":"Herranz D, Maraver A, Canamero M, Gomez-Lopez G, Inglada-Perez L, Robledo M et al. SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency. Oncogene 2013; 32: 4052\u20134056.","journal-title":"Oncogene"},{"key":"BFonc2013583_CR25","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.4161\/cc.6.23.5026","volume":"6","author":"Z Yuan","year":"2007","unstructured":"Yuan Z, Seto E . A functional link between SIRT1 deacetylase and NBS1 in DNA damage response. Cell Cycle 2007; 6: 2869\u20132871.","journal-title":"Cell Cycle"},{"key":"BFonc2013583_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.molcel.2010.07.006","volume":"39","author":"W Fan","year":"2010","unstructured":"Fan W, Luo J . SIRT1 regulates UV-induced DNA repair through deacetylating XPA. Molecular cell 2010; 39: 247\u2013258.","journal-title":"Molecular cell"},{"key":"BFonc2013583_CR27","doi-asserted-by":"publisher","first-page":"22623","DOI":"10.1073\/pnas.1010377108","volume":"107","author":"M Ming","year":"2010","unstructured":"Ming M, Shea CR, Guo X, Li X, Soltani K, Han W et al. Regulation of global genome nucleotide excision repair by SIRT1 through xeroderma pigmentosum C. Proc Natl Acad Sci USA 2010; 107: 22623\u201322628.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2013583_CR28","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S0962-8924(02)02342-5","volume":"12","author":"J Smith","year":"2002","unstructured":"Smith J . Human Sir2 and the 'silencing' of p53 activity. Trends Cell Biol 2002; 12: 404\u2013406.","journal-title":"Trends Cell Biol"},{"key":"BFonc2013583_CR29","doi-asserted-by":"publisher","first-page":"10794","DOI":"10.1073\/pnas.1934713100","volume":"100","author":"HL Cheng","year":"2003","unstructured":"Cheng HL, Mostoslavsky R, Saito S, Manis JP, Gu Y, Patel P et al. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci USA 2003; 100: 10794\u201310799.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2013583_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1474-9726.2006.00191.x","volume":"5","author":"C Kamel","year":"2006","unstructured":"Kamel C, Abrol M, Jardine K, He X, McBurney MW . SirT1 fails to affect p53-mediated biological functions. Aging Cell 2006; 5: 81\u201388.","journal-title":"Aging Cell"},{"issue":"52","key":"BFonc2013583_CR31","doi-asserted-by":"publisher","first-page":"22623","DOI":"10.1073\/pnas.1010377108","volume":"107","author":"M. Ming","year":"2010","unstructured":"Ming M, Shea CR, Guo X, Li X, Soltani K, Han W et al. Regulation of global genome nucleotide excision repair by SIRT1 through xeroderma pigmentosum C. Proc Natl Acad Sci USA 107: 22623\u201322628.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"BFonc2013583_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.molcel.2010.07.006","volume":"39","author":"Wei Fan","year":"2010","unstructured":"Fan W, Luo J . SIRT1 regulates UV-induced DNA repair through deacetylating XPA. Mol Cell 39: 247\u2013258.","journal-title":"Molecular Cell"},{"key":"BFonc2013583_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/emm.2007.2","volume":"39","author":"J Jeong","year":"2007","unstructured":"Jeong J, Juhn K, Lee H, Kim SH, Min BH, Lee KM et al. SIRT1 promotes DNA repair activity and deacetylation of Ku70. Exp Mol Med 2007; 39: 8\u201313.","journal-title":"Exp Mol Med"},{"key":"BFonc2013583_CR34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.molcel.2007.05.029","volume":"27","author":"Z Yuan","year":"2007","unstructured":"Yuan Z, Zhang X, Sengupta N, Lane WS, Seto E . SIRT1 regulates the function of the Nijmegen breakage syndrome protein. Mol Cell 2007; 27: 149\u2013162.","journal-title":"Mol Cell"},{"key":"BFonc2013583_CR35","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/carcin\/bgm282","volume":"29","author":"K Sugasawa","year":"2008","unstructured":"Sugasawa K . Xeroderma pigmentosum genes: functions inside and outside DNA repair. Carcinogenesis 2008; 29: 455\u2013465.","journal-title":"Carcinogenesis"},{"key":"BFonc2013583_CR36","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1523-1747.1998.00173.x","volume":"110","author":"RJ Berg","year":"1998","unstructured":"Berg RJ, Ruven HJ, Sands AT, de Gruijl FR, Mullenders LH . Defective global genome repair in XPC mice is associated with skin cancer susceptibility but not with sensitivity to UVB induced erythema and edema. J Invest Dermatol 1998; 110: 405\u2013409.","journal-title":"J Invest Dermatol"},{"key":"BFonc2013583_CR37","first-page":"1580","volume":"60","author":"DL Cheo","year":"2000","unstructured":"Cheo DL, Meira LB, Burns DK, Reis AM, Issac T, Friedberg EC . Ultraviolet B radiation-induced skin cancer in mice defective in the Xpc, Trp53, and Apex (HAP1) genes: genotype-specific effects on cancer predisposition and pathology of tumors. Cancer Res 2000; 60: 1580\u20131584.","journal-title":"Cancer Res"},{"key":"BFonc2013583_CR38","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrm2147","volume":"8","author":"KH Vousden","year":"2007","unstructured":"Vousden KH, Lane DP . p53 in health and disease. Nat Rev Mol Cell Biol 2007; 8: 275\u2013283.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2013583_CR39","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1128\/MCB.26.1.28-38.2006","volume":"26","author":"JM Solomon","year":"2006","unstructured":"Solomon JM, Pasupuleti R, Xu L, McDonagh T, Curtis R, DiStefano PS et al. Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage. Mol Cell Biol 2006; 26: 28\u201338.","journal-title":"Mol Cell Biol"},{"key":"BFonc2013583_CR40","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1038\/onc.2009.147","volume":"28","author":"G Boily","year":"2009","unstructured":"Boily G, He XH, Pearce B, Jardine K, McBurney MW . SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol. Oncogene 2009; 28: 2882\u20132893.","journal-title":"Oncogene"},{"key":"BFonc2013583_CR41","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1128\/MCB.23.1.38-54.2003","volume":"23","author":"MW McBurney","year":"2003","unstructured":"McBurney MW, Yang X, Jardine K, Hixon M, Boekelheide K, Webb JR et al. The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis. Mol Cell Biol 2003; 23: 38\u201354.","journal-title":"Mol Cell Biol"},{"key":"BFonc2013583_CR42","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1073\/pnas.0306551101","volume":"101","author":"T Itoh","year":"2004","unstructured":"Itoh T, Cado D, Kamide R, Linn S . DDB2 gene disruption leads to skin tumors and resistance to apoptosis after exposure to ultraviolet light but not a chemical carcinogen. Proc Natl Acad Sci USA 2004; 101: 2052\u20132057.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2013583_CR43","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1093\/carcin\/bgq164","volume":"31","author":"M Oka","year":"2010","unstructured":"Oka M, Edamatsu H, Kunisada M, Hu L, Takenaka N, Dien S et al. Enhancement of ultraviolet B-induced skin tumor development in phospholipase Cepsilon-knockout mice is associated with decreased cell death. Carcinogenesis 2010; 31: 1897\u20131902.","journal-title":"Carcinogenesis"},{"key":"BFonc2013583_CR44","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1186\/bcr1632","volume":"9","author":"H Li","year":"2007","unstructured":"Li H, Rajendran GK, Liu N, Ware C, Rubin BP, Gu Y . SirT1 modulates the estrogen-insulin-like growth factor-1 signaling for postnatal development of mammary gland in mice. Breast Cancer Res 2007; 9: R1.","journal-title":"Breast Cancer Res"},{"key":"BFonc2013583_CR45","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1038\/onc.2012.279","volume":"32","author":"CL Wu","year":"2013","unstructured":"Wu CL, Qiang L, Han W, Ming M, Viollet B, He YY . Role of AMPK in UVB-induced DNA damage repair and growth control. Oncogene 2013; 32: 2682\u20132689.","journal-title":"Oncogene"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2013583.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2013583","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2013583.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T19:15:36Z","timestamp":1647890136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2013583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,20]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,1,15]]}},"alternative-id":["BFonc2013583"],"URL":"https:\/\/doi.org\/10.1038\/onc.2013.583","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,20]]},"assertion":[{"value":"1 July 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KS serves on the board of directors in Elorac Pharma and receives stocks from Elorac Pharma, DUSA, Winston and Gideon Pharmaceuticals, but none of them are relevant to this study. All the other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}